Shinya Minatoguchi Selected Research

Shinya Minatoguchi Research Topics

Disease

49	Myocardial Infarction 09/2022 - 10/2002
36	Infarction (Infarctions) 01/2022 - 10/2002
27	Fibrosis (Cirrhosis) 07/2020 - 05/2005
21	Ischemia 01/2016 - 10/2002
20	Heart Failure 01/2022 - 08/2004
15	Hypertension (High Blood Pressure) 06/2023 - 04/2005
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2004
9	Cardiomyopathies (Cardiomyopathy) 01/2019 - 08/2004
7	Left Ventricular Dysfunction 01/2022 - 01/2004
7	Reperfusion Injury 01/2020 - 12/2007
7	Hypertrophy 10/2019 - 07/2005
7	Pathologic Constriction (Stenosis) 12/2015 - 07/2003
7	Coronary Occlusion 09/2011 - 08/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 03/2009
6	Atrial Fibrillation 03/2018 - 01/2012
6	Inflammation (Inflammations) 04/2015 - 09/2006
6	Cicatrix (Scar) 03/2009 - 06/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2007
5	Lung Neoplasms (Lung Cancer) 01/2019 - 03/2010
5	Thrombosis (Thrombus) 12/2012 - 05/2002
5	Ventricular Remodeling 10/2007 - 05/2003
4	Diabetes Mellitus 01/2019 - 05/2005
4	Heart Diseases (Heart Disease) 01/2019 - 02/2003
4	Peripheral Arterial Disease 02/2016 - 09/2006
4	Emphysema 12/2015 - 10/2006
4	Coronary Disease (Coronary Heart Disease) 10/2015 - 04/2006
4	Starvation 12/2012 - 05/2009
4	Proteinuria 03/2010 - 10/2007
3	Acute Coronary Syndrome 09/2022 - 05/2011
3	Sclerosis 07/2020 - 12/2005
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 12/2007
3	Chronic Renal Insufficiency 04/2019 - 04/2016
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019 - 02/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2002
3	Hypoxia (Hypoxemia) 07/2015 - 08/2010
3	Atherosclerosis 01/2015 - 01/2011
3	Hyperplasia 07/2013 - 05/2002
3	Pneumonia (Pneumonitis) 01/2012 - 01/2007
3	Cardiomegaly (Heart Hypertrophy) 07/2011 - 02/2003
3	Hemorrhage 01/2011 - 01/2010

Drug/Important Bio-Agent (IBA)

15	LipidsIBA 01/2023 - 05/2002
14	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2015 - 06/2004
13	Adenosine Triphosphate (ATP)IBA 12/2012 - 10/2002
10	SaltsIBA 06/2023 - 06/2003
8	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2017 - 06/2003
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 06/2003
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 01/2006
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2015 - 08/2004
8	Erythropoietin FDA Link 04/2013 - 01/2006
8	Hydroxyl RadicalIBA 07/2009 - 06/2003
7	Alprostadil (Muse)FDA LinkGeneric 01/2022 - 01/2018
7	Indicators and Reagents (Reagents)IBA 12/2009 - 06/2003
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 06/2003
6	Proteins (Proteins, Gene)FDA Link 03/2012 - 09/2002
6	KATP ChannelsIBA 10/2011 - 10/2002
5	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 02/2006
5	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019 - 06/2010
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 05/2009
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 12/2009
4	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2007
4	Prorenin ReceptorIBA 07/2020 - 01/2014
4	miglitol (Glyset)FDA Link 11/2019 - 07/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 10/2008
4	candesartanIBA 09/2013 - 02/2008
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2012 - 05/2009
4	Green Fluorescent ProteinsIBA 12/2012 - 05/2009
4	Superoxides (Superoxide)IBA 01/2012 - 04/2007
4	Nitric Oxide Synthase (NO Synthase)IBA 06/2010 - 06/2003
4	Fas Ligand Protein (Fas Ligand)IBA 02/2010 - 09/2004
4	Coloring Agents (Dyes)IBA 05/2009 - 06/2003
4	mitochondrial K(ATP) channelIBA 05/2009 - 01/2004
4	Nicorandil (SG 75)IBA 11/2007 - 07/2003
4	Protein Kinase CIBA 10/2007 - 10/2002
4	5-hydroxydecanoic acidIBA 04/2007 - 10/2002
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 01/2003
3	Troponin IIBA 01/2022 - 01/2006
3	Therapeutic UsesIBA 04/2019 - 07/2005
3	Angiotensin IIIBA 11/2018 - 02/2008
3	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 03/2009
3	oxidized low density lipoproteinIBA 01/2016 - 01/2014
3	Pravastatin (Pravachol)FDA LinkGeneric 04/2015 - 06/2005
3	pitavastatin (itavastatin)FDA Link 04/2015 - 02/2009
3	ReninIBA 01/2015 - 05/2007
3	Valsartan (Vals)FDA Link 09/2013 - 04/2007
3	Amlodipine (Norvasc)FDA LinkGeneric 09/2013 - 10/2007
3	Phosphotransferases (Kinase)IBA 12/2012 - 06/2004
3	Cathepsin DIBA 12/2012 - 05/2009
3	Pancreatic Elastase (Elastase)IBA 01/2012 - 10/2006
3	Amino Acids FDA Link 06/2011 - 05/2009
3	HydrogelsIBA 04/2011 - 09/2008
3	GelatinIBA 04/2011 - 09/2008

Therapy/Procedure

32	Therapeutics 01/2022 - 08/2004
7	Percutaneous Coronary Intervention 01/2023 - 01/2004
7	Ligation 07/2015 - 02/2003
3	Intravenous Administration 01/2020 - 02/2009
3	Catheter Ablation 06/2018 - 09/2013
3	Drug Therapy (Chemotherapy) 01/2017 - 07/2010
3	Oral Administration 07/2016 - 06/2010
3	Intraperitoneal Injections 01/2016 - 01/2006